Unicycive Therapeutics Inc (UNCY) — Financial Flexibility Index
Unicycive Therapeutics Inc (UNCY) has a Financial Flexibility Index of -0.41x as of June 2026. Free cash flow of $-7.60 Million (operating CF $-7.60 Million minus capex $1.00K) represents 0% of total liabilities ($18.76 Million). Check how tangible is Unicycive Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Unicycive Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Unicycive Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see Unicycive Therapeutics Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Unicycive Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Unicycive Therapeutics Inc. Explore Unicycive Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.65x | $-31.29 Million | $-31.32 Million | $18.94 Million | ▼ -40.5% |
| 2024 | -1.18x | $-28.50 Million | $-28.57 Million | $24.24 Million | ▼ -15.9% |
| 2023 | -1.02x | $-18.27 Million | $-18.28 Million | $18.00 Million | ▲ +78.7% |
| 2022 | -4.77x | $-15.65 Million | $-15.65 Million | $3.28 Million | ▼ -87.7% |
| 2021 | -2.54x | $-5.74 Million | $-5.77 Million | $2.26 Million | ▼ -410.5% |
| 2020 | -0.50x | $-1.43 Million | $-1.46 Million | $2.88 Million | ▲ +60.8% |
| 2019 | -1.27x | $-1.15 Million | $-1.18 Million | $903.00K | ▼ -110.3% |
| 2018 | -0.60x | $-746.00K | $-775.00K | $1.24 Million | — |